Actively Recruiting
Effectiveness and Implementation of Mobile Health Platform for Medication Management and E-Labeling (eDrugSafe)
Led by Seoul National University · Updated on 2024-11-27
360
Participants Needed
1
Research Sites
50 weeks
Total Duration
On this page
Sponsors
S
Seoul National University
Lead Sponsor
M
Ministry of Food and Drug Safety, Korea
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this cluster randomized trial is to learn if eDrugSafe, a mobile web platform for drug electronic labeling (e-labeling) and medication management, can improve medication adherence and self-efficacy in adults who take multiple medications. This study will also assess whether eDrugSafe is feasible and acceptable for use in real clinical settings, especially in local pharmacies. The main questions it aims to answer are: * Can eDrugSafe improve medication adherence, self-efficacy, and quality of life for adults taking multiple medications and reduce hospitalizations? * Is eDrugSafe acceptable and feasible for implementing drug e-labeling and supporting medication management in community settings? Researchers will compare eDrugSafe to usual care (traditional paper methods) to see if eDrugSafe is effective in supporting adults who take multiple medications, and if it can be feasibly implemented in local pharmacies. Participants will: * Visit a local pharmacy randomly assigned to use eDrugSafe or traditional care methods and decide if they wish to join the study. * Use either eDrugSafe to access medication information and manage their medication history, or receive usual care with paper-based methods, for 6 months. * Complete surveys at the start of the study, at 3 months, and at 6 months to measure effectiveness and implementation outcomes.
CONDITIONS
Official Title
Effectiveness and Implementation of Mobile Health Platform for Medication Management and E-Labeling (eDrugSafe)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 79 years
- Able to speak and understand Korean
- Have a personal electronic device that can access mobile applications and web services over wireless internet
- Taking three or more medications with at least one prescribed for 28 days or longer
- Provided direct consent to participate in the study
You will not qualify if you...
- Using any mobile web platform other than eDrugSafe for medication safety information after enrollment
- Do not consent to participate or withdraw consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University
Seoul, Gwanak-gu, South Korea, 08826
Actively Recruiting
Research Team
J
Jung-Mi Oh, Pharm.D
CONTACT
D
Da Eun Lee, Master, Pharm.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here